2025 Global Allergy Diagnostics Market Revenue Opportunities Report
Description
The 2025 Global Allergy Diagnostics Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global allergy diagnostics market are Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), and Canon, Inc. (Japan) via Minaris Medical America, Inc. Danaher, through its subsidiary Beckman Coulter, held the largest market share in 2023, offering sophisticated biomedical testing equipment used widely in allergy diagnostics. Thermo Fisher Scientific follows closely, recognized for its Phadia equipment, serving over 400,000 clients globally across many healthcare and research settings. Siemens Healthineers is also a key player, known for its broad innovations in diagnostic testing. Minaris Medical America, formerly Hitachi Chemical, is noted for its in vitro multiplex allergy diagnostic assays such as the OPTIGEN Allergen-Specific IgE test, distributed in over 20 countries.
These companies lead the allergy diagnostics sector by leveraging extensive research and development, cutting-edge technologies like multiplex testing platforms, and strategic global partnerships. They focus on enhancing diagnostic accuracy and patient outcomes while expanding access worldwide, particularly in emerging markets. Innovations such as Beckman Coulter’s Basophil Activation Test and the integration of AI and telemedicine reflect their commitment to improving allergy diagnosis and personalized treatment. Their dominant presence and continued investments contribute significantly to the market's robust growth, driven by the rising incidence of allergic diseases globally.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global allergy diagnostics market are Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), and Canon, Inc. (Japan) via Minaris Medical America, Inc. Danaher, through its subsidiary Beckman Coulter, held the largest market share in 2023, offering sophisticated biomedical testing equipment used widely in allergy diagnostics. Thermo Fisher Scientific follows closely, recognized for its Phadia equipment, serving over 400,000 clients globally across many healthcare and research settings. Siemens Healthineers is also a key player, known for its broad innovations in diagnostic testing. Minaris Medical America, formerly Hitachi Chemical, is noted for its in vitro multiplex allergy diagnostic assays such as the OPTIGEN Allergen-Specific IgE test, distributed in over 20 countries.
These companies lead the allergy diagnostics sector by leveraging extensive research and development, cutting-edge technologies like multiplex testing platforms, and strategic global partnerships. They focus on enhancing diagnostic accuracy and patient outcomes while expanding access worldwide, particularly in emerging markets. Innovations such as Beckman Coulter’s Basophil Activation Test and the integration of AI and telemedicine reflect their commitment to improving allergy diagnosis and personalized treatment. Their dominant presence and continued investments contribute significantly to the market's robust growth, driven by the rising incidence of allergic diseases globally.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
